Skip to main content Accessibility help
×
Home

Antihypertensive drug exposure in premature infants from 1997 to 2013

  • Srikanth Ravisankar (a1), Devon Kuehn (a1), Reese H. Clark (a2), Rachel G. Greenberg (a3), P. Brian Smith (a3) and Christoph P. Hornik (a3)...

Abstract

Background

Systemic hypertension is increasingly recognised in premature infants. There is limited evidence regarding treatment, and most published treatment recommendations are based solely on expert opinions.

Methods

We identified all infants born ⩽32 weeks of gestation and ⩽1500 g birth weight discharged from one of 348 neonatal ICUs managed by the Pediatrix Medical Group between 1997 and 2013. We defined antihypertensive drugs as vasodilators, angiotensin-converting enzyme inhibitors, β receptor blockers, calcium channel blockers, and central α2 receptor agonists. We compared characteristics between infants who were treated with at least one antihypertensive drug during their initial hospitalisation and infants who were not prescribed antihypertensive drugs using Wilcoxon’s ranked sum test or Pearson’s χ2-test.

Results

We identified 2504/119,360 (2.1%) infants who required at least one antihypertensive drug. The median postnatal age of first exposure was 48 days (25th, 75th percentile 15, 86), and the median length of therapy was 6 days (1, 16). Hydralazine was the most commonly prescribed antihypertensive with 1280/2504 (51.1%) treated infants exposed to the drug. More than two antihypertensive drugs were administered in 582/2504 (23.2%) infants, and 199/2097 (9.5%) of the treated infants were discharged home on antihypertensive therapy. Infants who received antihypertensive drugs were of lower gestational age (p<0.001) and birth weight (p<0.001) compared with infants not prescribed antihypertensive drugs.

Conclusions

Our study is the largest to describe current antihypertensive drug exposure in a cohort of exclusively premature infants born ⩽32 weeks of gestation. We found wide variations in practice for treating hypertension in premature infants.

Copyright

Corresponding author

Correspondence to: C. P. Hornik, MD, Assistant Professor of Pediatrics, Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27715, United States of America. Tel: +1 919 668 8935; Fax: +1 919 668 7032; E-mail: christoph.hornik@duke.edu

References

Hide All
1. Seliem, WA, Falk, MC, Shadbolt, B, Kent, AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol 2007; 22: 20812087.
2. Alagappan, A, Malloy, MH. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors. Am J Perinatol 1998; 15: 38.
3. Dionne, JM, Abitbol, CL, Flynn, JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 2012; 27: 1732.
4. Blowey, DL, Duda, PJ, Stokes, P, Hall, M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 2011; 5: 478483.
5. Sahu, R, Pannu, H, Yu, R, Shete, S, Bricker, JT, Gupta-Malhotra, M. Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr 2013; 163: 8488.
6. Hsieh, EM, Hornik, CP, Clark, RH, et al. Medication use in the neonatal intensive care unit. Am J Perinatol 2014; 31: 811822.
7. Singh, HP, Hurley, RM, Myers, TF. Neonatal hypertension. Incidence and risk factors. Am J Hypertens 1992; 5: 5155.
8. Buchi, KF, Siegler, RL. Hypertension in the first month of life. J Hypertens 1986; 4: 525528.
9. Skalina, ME, Kliegman, RM, Fanaroff, AA. Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol 1986; 3: 235239.
10. American Academy of Pediatrics Committee on Fetus and Newborn: routine evaluation of blood pressure, hematocrit, and glucose in newborns. Pediatrics 1993; 92: 474476.
11. de Swiet, M, Fayers, P, Shinebourne, EA. Systolic blood pressure in a population of infants in the first year of life: the Brompton study. Pediatrics 1980; 65: 10281035.
12. Pejovic, B, Peco-Antic, A, Marinkovic-Eric, J. Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol 2006; 22: 249257.
13. Kent, AL, Meskell, S, Falk, MC, Shadbolt, B. Normative blood pressure data in non-ventilated premature neonates from 28–36 weeks gestation. Pediatr Nephrol 2008; 24: 141146.
14. Lurbe, E, Garcia-Vicent, C, Torro, I, et al. First-year blood pressure increase steepest in low birthweight newborns. J Hypertens 2006; 25: 8186.
15. Zubrow, AB, Hulman, S, Kushner, H, Falkner, B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol 1995; 15: 470479.
16. Friedman, AL, Hustead, VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol 1987; 1: 3034.
17. O’Dea, RF, Mirkin, BL, Alward, CT, Sinaiko, AR. Treatment of neonatal hypertension with captopril. J Pediatr 1988; 113: 403406.
18. Guron, G, Friberg, P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 2000; 18: 123137.
19. Wells, TG, Bunchman, TE, Kearns, GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr 1990; 117: 664667.
20. Mason, T, Polak, MJ, Pyles, L, Mullett, M, Swanke, C. Treatment of neonatal renovascular hypertension with intravenous enalapril. Am J Perinatol 1992; 9: 254257.
21. Flynn, JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol 2000; 14: 332341.
22. Sheftel, DN, Hustead, V, Friedman, A. Hypertension screening in the follow-up of premature infants. Pediatrics 1983; 71: 763766.
23. Arar, MY, Hogg, RJ, Arant, BS, Seikaly, MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 1994; 8: 186189.
24. Shah, AB, Hashmi, S, Sahulee, R, Pannu, H, Gupta-Malhotra, M. Characteristics of systemic hypertension in preterm children. J Clin Hypertens (Greenwich) 2015; 17: 364370.
25. Chu, PY, Hill, KD, Clark, RH, Smith, PB, Hornik, CP. Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev 2015; 91: 345350.
26. Hsu, DT, Zak, V, Mahony, L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 2010; 122: 333340.

Keywords

Antihypertensive drug exposure in premature infants from 1997 to 2013

  • Srikanth Ravisankar (a1), Devon Kuehn (a1), Reese H. Clark (a2), Rachel G. Greenberg (a3), P. Brian Smith (a3) and Christoph P. Hornik (a3)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed